By targeting the RBD in S1 subunit and HR1 in S2 subunit of S protein, S-20-1 exhibited potent and broad-spectrum inhibitory activity against infection by SARS-CoV-2, its variants, and other HCoVs, as well as bat SARSr-CoVs. The gene discussed is CDCA7L; the disease is infection.